Journal Article

The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats

Koszegi, Sandor, Vannay, Adam, Zelena, Dora, Lenart, Lilla, Balogh, Dora, Szabo, Attila J., Hodrea, Judit, Veres-Szekely, Apor, Hosszu, Adam, Fekete, Andrea, Szkibinszkij, Edgar, Wagner, Laszlo

2016

Overview

Rationale Depression is highly prevalent in diabetes (DM). Brain-derived neurotrophic factor (BDNF) which is mainly regulated by the endoplasmic reticulum chaperon sigma-1 receptor (S1R) plays a relevant role in the development of depression. Objectives We studied the dose-dependent efficacy of S1R agonist fluvoxamine (FLU) in the prevention of DM-induced depression and investigated the significance of the S1R-BDNF pathway. Methods We used streptozotocin to induce DM in adult male rats that were treated for 2 weeks p.o. with either different doses of FLU (2 or 20 mg/bwkg) or FLU + S1R antagonist NE100 (1 mg/bwkg) or vehicle. Healthy controls were also enrolled. Metabolic, behaviour, and neuroendocrine changes were determined, and S1R and BDNF levels were measured in the different brain regions. Results In DM rats, immobility time was increased, adrenal glands were enlarged, and thymuses were involuted. FLU in 20 mg/bwkg, but not in 2 mg/bwkg dosage, ameliorated depression-like behaviour. S1R and BDNF protein levels were decreased in DM, while FLU induced SIR-BDNF production. NE100 suspended all effects of FLU. Conclusions We suggest that disturbed S1R-BDNF signaling in the brain plays a relevant role in DM-induced depression. The activation of this cascade serves as an additional target in the prevention of DM-associated depression.

• Publisher: Springer Berlin Heidelberg,Springer,Springer Nature B.V
• Subject: Animals / Anisoles - pharmacology / Biomedical and Life Sciences / Biomedicine / Brain / Brain - drug effects / Brain - metabolism / Brain-derived neurotrophic factor / Brain-Derived Neurotrophic Factor - metabolism / Comorbidity / Depression (Mood disorder) / Depression - complications / Depression - metabolism / Depressive Disorder - drug therapy / Depressive Disorder - metabolism / Development and progression / Diabetes / Diabetes mellitus / Diabetes Mellitus, Experimental - complications / Diabetes Mellitus, Experimental - metabolism / Fluvoxamine - pharmacology / Fluvoxamine - therapeutic use / Health aspects / Male / Mental depression / Narcotic Antagonists - pharmacology / Neurosciences / Original Investigation / Pharmacology/Toxicology / Physiological aspects / Propylamines - pharmacology / Psychiatry / Psychological aspects / Rats / Receptors, sigma - antagonists & inhibitors / Receptors, sigma - metabolism / Selective Serotonin Reuptake Inhibitors - pharmacology / Selective Serotonin Reuptake Inhibitors - therapeutic use / Sigma-1 Receptor / Signal Transduction - drug effects